SubHero Banner

Lemtrada® (alemtuzumab) – New warning

November 29, 2018 - The FDA announced that a new warning about the rare but serious cases of stroke and tears in the lining of arteries in the head and neck occurring in patients taking Lemtrada (alemtuzumab) will be added to the Lemtrada drug label and patient Medication Guide. The risk of stroke will also be added to Lemtrada’s Boxed Warning.

Download PDF